Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): A randomised, open-label, multicentre, non-inferiority phase 3 study

Richard E. Pratley, Michael A. Nauck, Anthony H. Barnett, Mark N. Feinglos, Fernando Ovalle, Illana Harman-Boehm, June Ye, Rhona Scott, Susan Johnson, Murray Stewart, Julio Rosenstock

    Research output: Contribution to journalArticlepeer-review

    262 Scopus citations

    Fingerprint

    Dive into the research topics of 'Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): A randomised, open-label, multicentre, non-inferiority phase 3 study'. Together they form a unique fingerprint.

    Medicine & Life Sciences